Biotech

All Articles

Takeda takes $140M loss on stopped working epilepsy drug, promotes FDA run

.Our team presently know that Takeda is actually wanting to find a road to the FDA for epilepsy medi...

VBI Injections apply for personal bankruptcy, seeks resource sale

.Immunology biotech VBI Vaccinations is actually drifting dangerously near to the point of no return...

Celldex anti-cKIT antibody lower hives in one more stage 2 study

.It's hard to muscular tissue in on a room as affordable as immunology, however Celldex Rehabs belie...

Boehringer provides to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapies as well as a preclinical immu...

Ventyx's last hope for inflamed med ends in Crohn's failing

.Ventyx Biosciences' Crohn's health condition medication did certainly not help individuals achieve ...

Cognition's period 2 beam records blemish Alzheimer's prospect

.Knowledge Therapeutics' phase 2 luster test has actually taken a number of the radiance off the Alz...

BMS axes bispecific months after filing to work stage 3 trial

.Bristol Myers Squibb has had a whiplash change of heart on its own BCMA bispecific T-cell engager, ...

Charles Baum takes control of Terremoto as CEO

.Charles Baum, M.D., Ph.D., who looked after Mirati Rehabs' $ 5.8 billion purchase to Bristol Myers ...

Asarina to close after efforts to companion Tourette's medicine fail

.After communicating to greater than 200 firms to partner a Tourette disorder treatment that showed ...

Novartis pens $150M beforehand bispecifics manage Dren Biography

.Novartis has actually possessed some bad luck along with bispecific antibodies before, however judg...